Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding.

Frontiers in immunology·2026
Same author

Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.

Lancet (London, England)·2026
Same author

Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial.

The Lancet. Rheumatology·2026
Same author

Editorial: Exploring innovative therapies for rare inflammatory skin diseases.

Frontiers in medicine·2026
Same author

Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International Cohort.

Dermatology and therapy·2026
Same author

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

Frontiers in immunology·2025

Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

969

Biomarkers for psoriasis skin lesions.

Angelo M D' Erme1,2, Francesca Papadia3, Joerg Wenzel4

  • 1Unit of Dermatology, Livorno Hospital, Livorno, Italy - a.m.derme@gmail.com.

Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|May 24, 2017
PubMed
Summary

Diagnosing psoriasis can be challenging, relying on clinical features. This review highlights key skin biomarkers (BMs) to differentiate psoriasis from other skin conditions, aiding accurate diagnosis and treatment.

More Related Videos

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

15.2K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 2, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

969
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

15.2K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

1.3K

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Psoriasis is a prevalent chronic skin condition with diagnosis primarily based on clinical presentation.
  • Accurate diagnosis is essential for effective therapeutic choices, yet can be challenging in some cases.
  • Existing research on specific skin biomarkers for psoriasis lacks large-scale validation and clinical application.

Purpose of the Study:

  • To provide an overview of skin biomarkers for psoriasis.
  • To distinguish between inflammatory and epidermal biomarkers.
  • To identify distinctive biomarkers that aid in differentiating psoriasis from psoriasiform dermatitis.

Main Methods:

  • Literature review of studies investigating genes and proteins as potential psoriasis biomarkers.
  • Categorization of biomarkers into inflammatory and epidermal types.
  • Analysis of biomarker distinctiveness for diagnostic utility.

Main Results:

  • Numerous potential skin biomarkers have been reported in scientific literature.
  • No single biomarker has achieved regulatory approval or widespread clinical use due to insufficient large-scale testing.
  • Specific biomarkers show promise in distinguishing psoriasis from other inflammatory skin conditions.

Conclusions:

  • Skin biomarkers offer potential for improving psoriasis diagnosis.
  • Further large-scale studies are needed to validate biomarkers for clinical application.
  • Distinguishing psoriasis from psoriasiform dermatitis using biomarkers can guide treatment decisions.